Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine
G. Sapkal, P. Yadav, R. Ella, P. Abraham, D. Patil, N. Gupta, S. Panda, K. M. V, B. Bhargava
This study evaluates the neutralizing efficacy of B.1.1.28.2 variant against sera from natural infection and BBV152 vaccine recipients, showing reduced neutralization compared to D614G.
bioRxiv · Apr 30, 2021 · PreprintMicrobiology